Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53) - Image 1

£147.75

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Name: Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Brand: Springer
Price: 147.75 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 29 days • 29 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price

Price Analysis

Most common price: £148 (29 days, 100.0%)

Price range: £148 - £148

Price levels: 1 different prices over 29 days

Description

This book is based on invited presentations at the Ninth International Catecholamine Symposiwn. Over several decades, each International Catecholamine Symposiwn (ICS) has provided a uniquely important forwn for updating basic as well as clinical research on the catecholamines, dopamine, norepinephrine, and epinephrine. The first ICS took nd n1 place in Bethesda, Maryland, in the USA in 1958; the 2 in Milan, Italy in 1965; the 3 th in Strasbourg, France in 1973; the 4th in Asilomar, California, USA in 1978; the 5 in th th Goteborg, Sweden in 1983; the 6 in Jerusalem, Israel,in 1987; the 7 in Amsterdam, th Netherlands in 1992; and the 8 in Asilomar, California, USA in 1996. th The 9 International Catecholamine Symposiwn (9ICS) was held in Kyoto, Japan, th March 31-April 5, 2001. This ICS was held concurrently with the 5 International th Conference on Progress in Alzheimer's and Parkinson's Disease (5 ADPD). These international meetings were coordinated to be a joint international congress. Catecholamines and related neurotransmitters and neuromediators play important roles in the pathogenesis of symptoms and neurodegenerative processes of Alzheimer's disease and Parkinson's disease. Therefore, the Joint Congress provided an opportunity for investigators and clinicians working in these fields to exchange their· most recent investigational results and clinical experiences. This Joint International Congress turned out to be an enormous success, attended by 1258 participants from 38 countries, in an enthusiastic and pleasant atmosphere.

Product Specifications

Brand: Springer
Format: Paperback
ASIN: 1441933883
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 06 December 2010
Listed Since: 06 July 2010

Barcode

No barcode data available

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

The Central Catecholaminergic System - Neuroscience Research

Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Adenosine Receptors in Neurodegenerative Diseases

Academic Press Handbook of Behavioral Neurobiology of Serotonin

Cholinergic Mechanisms: Phylogenetic Aspects, Central and Peripheral Synapses, and Clinical Significance: 25 (Advances in Behavioral Biology, 25)

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)

Role of Melatonin and Pineal Peptides in Neuroimmunomodulation: Workshop Proceedings: 204 (NATO Science Series A: Life Sciences)

Current Hypotheses and Research Milestones in Alzheimer's Disease

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment: 5 (Current Topics in Neurotoxicity)